UNSPSC 51385700: Nonsteroidal anti inflammatory sulfonamides

Nonsteroidal anti inflammatory drugs made of a group of compounds that contain the structure SO2NH2.

UNSPSC 51385700 Nonsteroidal anti-inflammatory sulfonamides is a Class code, but recent state and local opportunities posted under it do not align with the code's nominal pharmaceutical classification — instead, the issuing bodies are soliciting naloxone, drug deactivation systems, direct-to-manufacturer prescription programs, and generic multi-source pharmaceuticals with OTC products, none of which fall within the sulfonamide anti-inflammatory category. The mismatch suggests either systematic miscoding by the procurement offices or that this code serves as a catch-all for pharmaceutical procurement activity more broadly. State and local buyers appear to be using this code to tag pharmaceutical supply agreements involving health departments, state human services commissions, and cooperative purchasing alliances, with deliverables ranging from emergency-response medication (naloxone) to high-volume generic drug distribution networks serving multiple jurisdictions simultaneously.

Recent activity spans Florida, Texas, and Minnesota. Seminole County, Florida issued IFB 60459723LAS in June 2026 seeking annual procurement of 1,900 units of naloxone and 800 safe drug deactivation systems for quarterly delivery to the county community health building, with responses due July 26, 2023. The Texas Health and Human Services Commission issued RFI HHS0017013 in April 2026 to gather vendor capabilities for a Therapeutic Pharmacy Initiative direct-to-manufacturer prescription program, signaling early-stage market research before a formal RFP. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, released RFP S1070000015802 in January 2026 for generic multi-source pharmaceuticals and OTC products distributed through three authorized wholesalers, with proposals due March 26, 2026 and contract start July 1, 2026. The MMCAP vehicle extends to Oregon, indicating multi-state scope. Issuing bodies include county health agencies, state health and human services departments, and cooperative purchasing platforms that aggregate demand across state and local jurisdictions.